Categories AlphaGraphs, Earnings, Health Care
A visual representation of Pfizer Inc. (NYSE: PFE) Q1 2020 earnings results
Pfizer Inc. (NYSE: PFE) Tuesday reported a decline in first-quarter earnings and revenues. However, the results exceeded analysts’ forecast.
Earnings, on an adjusted basis, dropped to $0.80 per share from $0.85 per share in the first quarter of 2019. The pharma company reported unadjusted profit of $3.4 billion or $0.61 per share for the three-month period, down from last year’s $3.88 billion or $0.68 per share. Earnings, meanwhile, came in above the estimates.
The weakens in the bottom-line performance is attributable to a 8% decline in revenues to $12 billion. Analysts were looking for a slightly lower number.
Shares of Pfizer closed the last trading session higher and continued to gain during Tuesday’s pre-market session. The stock has declined 7% in the past twelve months.
[irp posts=”54121″]
Most Popular
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights
Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose
Meta Platforms (META) set to report Q1 earnings. Here’s what to expect
After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently
